These outcomes, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 guidance the concept of focusing on ACKR3 as a novel method to modulate the opioid program, which could open new therapeutic avenues for opioid-connected Issues.At that time, Microsoft Promotion will make use o